Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection

In HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral Envelope (Env) resulting in prominent sequence diversification among geographical areas. The basal induction patterns of HIV Env-specific B cells...

Full description

Saved in:
Bibliographic Details
Published inAIDS (London) Vol. 36; no. 12; pp. 1629 - 1641
Main Authors Hau, Trang Thi Thu, Nishizawa, Masako, Harada, Shigeyoshi, Phan, My Ha, Kanno, Yoshiaki, Nomura, Takushi, Matsuoka, Saori, Kawana-Tachikawa, Ai, Hall, William W., Matano, Tetsuro, Nguyen, Lan Anh Thi, Yamamoto, Hiroyuki
Format Journal Article
LanguageEnglish
Published England Lippincott Williams & Wilkins 01.10.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract In HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral Envelope (Env) resulting in prominent sequence diversification among geographical areas. The basal induction patterns of HIV Env-specific B cells and their interaction with HIV Env awaits clarification. We investigated the relationship of Env polymorphisms and Env-specific B-cell responses in treatment-naive HIV-1 CRF01_AE-infected Vietnamese. Samples of 43 HIV-1 CRF01_AE infection-identified individuals were divided into acute-phase ( n  = 12) and chronic-phase ( n  = 31) by combined criteria of serological recent-infection assay and clinical parameters. We quantified subcloning-based polymorphic residue site numbers in plasma-derived Env variable region 1-5 (V1-V5)-coding regions within each individual, designating their summation within each region as variant index. Peripheral blood Env gp 140-specific B-cell responses and plasma neutralizing activity of Env pseudoviruses were examined to analyze their relationship with variant index. HIV-1 CRF01_AE Env gp140-specific total B-cell and plasma cell (CD19 + IgD - CD27 + CD38 + CD138 + ) responses were determined. In chronic-phase samples, significant correlation of variant index in all Env V1-V5 regions with Env-specific plasma cell responses was shown, and V1-V5 total variant index correlated stronger with Env-specific plasma cell as compared with total Env-specific B-cell responses. Env V5 variant index was significantly higher in chronic-phase cross-neutralizers of V5-polymorphic/VRC01-insensitive CRF01_AE Env. Results revealed the association between circulating Env-specific plasma cell responses and Env polymorphisms, implicating selective pressure on Env by plasma cell-derived antibodies and conversely suggests that Env-specific B-cell induction alone is insufficient for exerting Env selective pressure in HIV infection.
AbstractList In HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral Envelope (Env) resulting in prominent sequence diversification among geographical areas. The basal induction patterns of HIV Env-specific B cells and their interaction with HIV Env awaits clarification. We investigated the relationship of Env polymorphisms and Env-specific B-cell responses in treatment-naive HIV-1 CRF01_AE-infected Vietnamese. Samples of 43 HIV-1 CRF01_AE infection-identified individuals were divided into acute-phase ( n  = 12) and chronic-phase ( n  = 31) by combined criteria of serological recent-infection assay and clinical parameters. We quantified subcloning-based polymorphic residue site numbers in plasma-derived Env variable region 1-5 (V1-V5)-coding regions within each individual, designating their summation within each region as variant index. Peripheral blood Env gp 140-specific B-cell responses and plasma neutralizing activity of Env pseudoviruses were examined to analyze their relationship with variant index. HIV-1 CRF01_AE Env gp140-specific total B-cell and plasma cell (CD19 + IgD - CD27 + CD38 + CD138 + ) responses were determined. In chronic-phase samples, significant correlation of variant index in all Env V1-V5 regions with Env-specific plasma cell responses was shown, and V1-V5 total variant index correlated stronger with Env-specific plasma cell as compared with total Env-specific B-cell responses. Env V5 variant index was significantly higher in chronic-phase cross-neutralizers of V5-polymorphic/VRC01-insensitive CRF01_AE Env. Results revealed the association between circulating Env-specific plasma cell responses and Env polymorphisms, implicating selective pressure on Env by plasma cell-derived antibodies and conversely suggests that Env-specific B-cell induction alone is insufficient for exerting Env selective pressure in HIV infection.
In HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral Envelope (Env) resulting in prominent sequence diversification among geographical areas. The basal induction patterns of HIV Env-specific B cells and their interaction with HIV Env awaits clarification.OBJECTIVEIn HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral Envelope (Env) resulting in prominent sequence diversification among geographical areas. The basal induction patterns of HIV Env-specific B cells and their interaction with HIV Env awaits clarification.We investigated the relationship of Env polymorphisms and Env-specific B-cell responses in treatment-naive HIV-1 CRF01_AE-infected Vietnamese.DESIGNWe investigated the relationship of Env polymorphisms and Env-specific B-cell responses in treatment-naive HIV-1 CRF01_AE-infected Vietnamese.Samples of 43 HIV-1 CRF01_AE infection-identified individuals were divided into acute-phase ( n  = 12) and chronic-phase ( n  = 31) by combined criteria of serological recent-infection assay and clinical parameters. We quantified subcloning-based polymorphic residue site numbers in plasma-derived Env variable region 1-5 (V1-V5)-coding regions within each individual, designating their summation within each region as variant index. Peripheral blood Env gp 140-specific B-cell responses and plasma neutralizing activity of Env pseudoviruses were examined to analyze their relationship with variant index.METHODSSamples of 43 HIV-1 CRF01_AE infection-identified individuals were divided into acute-phase ( n  = 12) and chronic-phase ( n  = 31) by combined criteria of serological recent-infection assay and clinical parameters. We quantified subcloning-based polymorphic residue site numbers in plasma-derived Env variable region 1-5 (V1-V5)-coding regions within each individual, designating their summation within each region as variant index. Peripheral blood Env gp 140-specific B-cell responses and plasma neutralizing activity of Env pseudoviruses were examined to analyze their relationship with variant index.HIV-1 CRF01_AE Env gp140-specific total B-cell and plasma cell (CD19 + IgD - CD27 + CD38 + CD138 + ) responses were determined. In chronic-phase samples, significant correlation of variant index in all Env V1-V5 regions with Env-specific plasma cell responses was shown, and V1-V5 total variant index correlated stronger with Env-specific plasma cell as compared with total Env-specific B-cell responses. Env V5 variant index was significantly higher in chronic-phase cross-neutralizers of V5-polymorphic/VRC01-insensitive CRF01_AE Env.RESULTSHIV-1 CRF01_AE Env gp140-specific total B-cell and plasma cell (CD19 + IgD - CD27 + CD38 + CD138 + ) responses were determined. In chronic-phase samples, significant correlation of variant index in all Env V1-V5 regions with Env-specific plasma cell responses was shown, and V1-V5 total variant index correlated stronger with Env-specific plasma cell as compared with total Env-specific B-cell responses. Env V5 variant index was significantly higher in chronic-phase cross-neutralizers of V5-polymorphic/VRC01-insensitive CRF01_AE Env.Results revealed the association between circulating Env-specific plasma cell responses and Env polymorphisms, implicating selective pressure on Env by plasma cell-derived antibodies and conversely suggests that Env-specific B-cell induction alone is insufficient for exerting Env selective pressure in HIV infection.CONCLUSIONResults revealed the association between circulating Env-specific plasma cell responses and Env polymorphisms, implicating selective pressure on Env by plasma cell-derived antibodies and conversely suggests that Env-specific B-cell induction alone is insufficient for exerting Env selective pressure in HIV infection.
Author Kanno, Yoshiaki
Harada, Shigeyoshi
Hau, Trang Thi Thu
Kawana-Tachikawa, Ai
Matano, Tetsuro
Nishizawa, Masako
Phan, My Ha
Matsuoka, Saori
Hall, William W.
Yamamoto, Hiroyuki
Nomura, Takushi
Nguyen, Lan Anh Thi
AuthorAffiliation AIDS Research Center, National Institute of Infectious Diseases
Centre for Bio-Medical Research, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
AuthorAffiliation_xml – name: Centre for Bio-Medical Research, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
– name: AIDS Research Center, National Institute of Infectious Diseases
Author_xml – sequence: 1
  givenname: Trang Thi Thu
  surname: Hau
  fullname: Hau, Trang Thi Thu
  organization: AIDS Research Center, National Institute of Infectious Diseases
– sequence: 2
  givenname: Masako
  surname: Nishizawa
  fullname: Nishizawa, Masako
  organization: AIDS Research Center, National Institute of Infectious Diseases
– sequence: 3
  givenname: Shigeyoshi
  surname: Harada
  fullname: Harada, Shigeyoshi
  organization: AIDS Research Center, National Institute of Infectious Diseases
– sequence: 4
  givenname: My Ha
  surname: Phan
  fullname: Phan, My Ha
  organization: Centre for Bio-Medical Research, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
– sequence: 5
  givenname: Yoshiaki
  surname: Kanno
  fullname: Kanno, Yoshiaki
  organization: AIDS Research Center, National Institute of Infectious Diseases
– sequence: 6
  givenname: Takushi
  surname: Nomura
  fullname: Nomura, Takushi
  organization: AIDS Research Center, National Institute of Infectious Diseases
– sequence: 7
  givenname: Saori
  surname: Matsuoka
  fullname: Matsuoka, Saori
  organization: AIDS Research Center, National Institute of Infectious Diseases
– sequence: 8
  givenname: Ai
  surname: Kawana-Tachikawa
  fullname: Kawana-Tachikawa, Ai
  organization: AIDS Research Center, National Institute of Infectious Diseases
– sequence: 9
  givenname: William W.
  surname: Hall
  fullname: Hall, William W.
  organization: Centre for Bio-Medical Research, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
– sequence: 10
  givenname: Tetsuro
  surname: Matano
  fullname: Matano, Tetsuro
  organization: AIDS Research Center, National Institute of Infectious Diseases
– sequence: 11
  givenname: Lan Anh Thi
  surname: Nguyen
  fullname: Nguyen, Lan Anh Thi
  organization: Centre for Bio-Medical Research, National Institute of Hygiene and Epidemiology, Hanoi, Vietnam
– sequence: 12
  givenname: Hiroyuki
  surname: Yamamoto
  fullname: Yamamoto, Hiroyuki
  organization: AIDS Research Center, National Institute of Infectious Diseases
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35848590$$D View this record in MEDLINE/PubMed
BookMark eNqNkUFv1DAQhS3Uim5b_gFCPnJxO46TOOG2LC2tVKkCUa6W44ypwWsHO9kK8efJdrdS1RNzmdHoeyPNe8fkIMSAhLzlcMahledflp_O4FkJUYhXZMFLKVhVSX5AFlDULWuFhCNynPPPGaqgaV6TI1E1ZVO1sCB_lzlH4_ToYqDRUgwb9HFAlgc0zjpDPzKD3tPeWYsJw7hndejpxiXtaUaPZnQbpEPCnKeENLsfQY_zlKkL9Or6O-N09fUSuFpezBu75WM4JYdW-4xv9v2E3F1efFtdsZvbz9er5Q0zJW8Ea3spu7qVBirRdsbUCNBYsGVnuJaSY1dJa0ppmkLWHZel6Ctdl21ttaxQ9OKEvN_dHVL8PWEe1drl7VM6YJyyml3iZQ1SwIy-26NTt8ZeDcmtdfqjngybgQ87wKSYc0KrjBsfHRmTdl5xUNt01JyOepnOLC5fiJ_u_5_sIfoRU_7lpwdM6h61H-8f8QIEsAKKggNwYDvlPwBcoNk
CitedBy_id crossref_primary_10_7554_eLife_88849_4
crossref_primary_10_7554_eLife_88849
Cites_doi 10.1111/imr.12508
10.1038/ni1281
10.1089/aid.2019.0179
10.1038/nm1520
10.1371/journal.ppat.1005369
10.1038/nature12746
10.1128/JVI.00557-16
10.1016/j.micinf.2018.10.001
10.1371/journal.ppat.1007819
10.1371/journal.pone.0189999
10.1371/journal.pone.0026244
10.1016/j.bbrc.2018.11.063
10.1038/mi.2014.69
10.1038/nature07746
10.1097/QAD.0000000000003013
10.1371/journal.ppat.1003738
10.7448/IAS.17.1.19053
10.1371/journal.pone.0024078
10.1038/nature01470
10.1038/nature12744
10.1016/j.meegid.2011.04.034
10.1128/JVI.03608-14
10.1186/1742-4690-9-22
10.1038/nature07930
10.1128/JVI.00828-17
10.1128/JVI.75.22.10892-10905.2001
10.1371/journal.pmed.1000107
10.1038/nm.2985
10.1038/nature21435
10.1128/JVI.72.1.164-169.1998
10.1097/QAD.0b013e328342ff93
10.1089/088922203322493111
10.1097/QAD.0000000000001906
10.1016/j.path.2015.09.009
10.1056/NEJMoa0908492
10.1016/j.virol.2009.11.003
10.1038/nature12053
10.1016/j.vaccine.2018.10.084
10.4049/jimmunol.0901068
10.1099/jgv.0.001198
10.1089/aid.2005.21.586
10.1128/jvi.67.11.6642-6647.1993
10.1016/j.cell.2014.06.022
10.1073/pnas.181347898
10.1084/jem.20032236
10.1038/31405
10.1089/aid.1998.14.1687
10.1097/QAD.0000000000002620
10.1097/QAD.0000000000000969
10.1038/nm1244
10.1016/j.jim.2008.11.012
10.1038/nri3795
10.1126/science.1192819
10.1182/blood-2005-11-013383
10.1371/journal.pone.0008805
10.7554/eLife.62648
10.1371/journal.pone.0114947
10.1016/j.micinf.2015.12.009
10.1126/science.1086907
10.1128/JVI.01583-08
10.1186/1742-4690-11-32
10.1007/s00705-018-4011-7
10.1089/aid.2016.0029
ContentType Journal Article
Copyright Lippincott Williams & Wilkins
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Copyright_xml – notice: Lippincott Williams & Wilkins
– notice: Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1097/QAD.0000000000003323
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1473-5571
EndPage 1641
ExternalDocumentID 35848590
10_1097_QAD_0000000000003323
00002030-202210010-00003
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.XZ
.Z2
01R
0R~
1J1
23M
2WC
354
40H
4Q1
4Q2
4Q3
5GY
5RE
5VS
71W
77Y
7O~
85S
8L-
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AASXQ
AAUEB
AAXQO
ABASU
ABBUW
ABDIG
ABIVO
ABJNI
ABPXF
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACDDN
ACDOF
ACEWG
ACGFS
ACILI
ACLDA
ACOAL
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADGGA
ADHPY
AE3
AE6
AEBDS
AENEX
AFBFQ
AFDTB
AFEXH
AFMBP
AFNMH
AFSOK
AFUWQ
AGINI
AHOMT
AHQNM
AHQVU
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BOYCO
BQLVK
BYPQX
C45
CS3
DIK
DIWNM
E.X
E3Z
EBS
EEVPB
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
GNXGY
GQDEL
H0~
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JK3
JK8
K8S
KD2
KMI
KQ8
L-C
L7B
N9A
N~7
N~B
O9-
OAG
OAH
OBH
ODMTH
OHH
OHYEH
OK1
OL1
OLB
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
OPX
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P2P
RIG
RLZ
S4R
S4S
SJN
TEORI
TR2
TSPGW
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
AAYXX
CITATION
ACIJW
AWKKM
CGR
CUY
CVF
ECM
EIF
NPM
ODA
OJAPA
OLW
7X8
ID FETCH-LOGICAL-c4183-9d77b697c0539bcc6e008f0f4bc1a771eb57fc47c8276b1743d5a6496fa75e3d3
ISSN 0269-9370
1473-5571
IngestDate Thu Jul 10 23:36:37 EDT 2025
Wed Feb 19 02:24:45 EST 2025
Thu Jul 03 08:21:58 EDT 2025
Thu Apr 24 22:57:20 EDT 2025
Fri May 16 03:52:26 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 12
Language English
License Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4183-9d77b697c0539bcc6e008f0f4bc1a771eb57fc47c8276b1743d5a6496fa75e3d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 35848590
PQID 2691460730
PQPubID 23479
PageCount 13
ParticipantIDs proquest_miscellaneous_2691460730
pubmed_primary_35848590
crossref_citationtrail_10_1097_QAD_0000000000003323
crossref_primary_10_1097_QAD_0000000000003323
wolterskluwer_health_00002030-202210010-00003
PublicationCentury 2000
PublicationDate 2022-October-1
PublicationDateYYYYMMDD 2022-10-01
PublicationDate_xml – month: 10
  year: 2022
  text: 2022-October-1
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle AIDS (London)
PublicationTitleAlternate AIDS
PublicationYear 2022
Publisher Lippincott Williams & Wilkins
Publisher_xml – name: Lippincott Williams & Wilkins
References Lan (R16-20250608) 2003; 19
Cizmeci (R57-20250608) 2021; 10
Kawashima (R4-20250608) 2009; 458
Van Tran (R22-20250608) 2016; 30
Bussmann (R40-20250608) 2010; 397
Moir (R39-20250608) 2004; 200
Anthony (R10-20250608) 2017; 91
Hemelaar (R14-20250608) 2011; 25
Gao (R12-20250608) 2014; 158
Wei (R52-20250608) 2003; 422
Dhande (R55-20250608) 2020; 34
Wang (R26-20250608) 2018; 163
Wibmer (R11-20250608) 2013; 9
Bonsignori (R41-20250608) 2009; 183
Takahashi (R23-20250608) 2019; 21
Wardemann (R46-20250608) 2003; 301
Frahm (R2-20250608) 2006; 7
Kanno (R63-20250608) 2021; 35
Utachee (R24-20250608) 2014; 11
Kwong (R5-20250608) 1998; 393
Nishimura (R61-20250608) 2017; 543
Matano (R1-20250608) 1998; 72
Bontell (R29-20250608) 2012; 12
Lazaro (R21-20250608) 2011; 6
Muster (R50-20250608) 1993; 67
Titanji (R38-20250608) 2006; 108
Beretta (R44-20250608) 2018; 32
Rerks-Ngarm (R31-20250608) 2009; 361
Lynch (R36-20250608) 2015; 89
Lazaro (R20-20250608) 2005; 21
Ji (R30-20250608) 2018; 36
Sacha (R56-20250608) 2015; 8
Barouch (R60-20250608) 2013; 503
Scheid (R47-20250608) 2009; 343
Shingai (R59-20250608) 2013; 503
Li (R17-20250608) 2016; 32
Duong (R32-20250608) 2015; 10
Iseda (R62-20250608) 2016; 90
Scheid (R45-20250608) 2009; 458
Liao (R9-20250608) 2013; 496
Beyrer (R15-20250608) 1998; 14
Kelsoe (R6-20250608) 2017; 275
Mouquet (R48-20250608) 2011; 6
Levesque (R8-20250608) 2009; 6
Thida (R27-20250608) 2019; 508
Trkola (R58-20250608) 2005; 11
Doria-Rose (R54-20250608) 2009; 83
Olteanu (R34-20250608) 2016; 9
Chaitaveep (R25-20250608) 2016; 18
Nutt (R33-20250608) 2015; 15
Zhou (R35-20250608) 2010; 329
Kiepiela (R3-20250608) 2007; 13
Kraft (R42-20250608) 2012; 9
Moir (R7-20250608) 2001; 98
Jiamsakul (R28-20250608) 2014; 17
Moore (R13-20250608) 2012; 18
Chen (R18-20250608) 2019; 100
Corti (R49-20250608) 2010; 5
Sasaki (R19-20250608) 2020; 36
Zwick (R51-20250608) 2001; 75
Landais (R53-20250608) 2016; 12
Kafando (R43-20250608) 2017; 12
Zhou (R37-20250608) 2019; 15
References_xml – volume: 275
  start-page: 79
  year: 2017
  ident: R6-20250608
  article-title: Host controls of HIV broadly neutralizing antibody development
  publication-title: Immunol Rev
  doi: 10.1111/imr.12508
– volume: 7
  start-page: 173
  year: 2006
  ident: R2-20250608
  article-title: Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
  publication-title: Nat Immunol
  doi: 10.1038/ni1281
– volume: 36
  start-page: 242
  year: 2020
  ident: R19-20250608
  article-title: Characterization of HIV-1 CRF01_AE env genes derived from recently infected Indonesian individuals
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2019.0179
– volume: 13
  start-page: 46
  year: 2007
  ident: R3-20250608
  article-title: CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
  publication-title: Nat Med
  doi: 10.1038/nm1520
– volume: 12
  start-page: e1005369
  year: 2016
  ident: R53-20250608
  article-title: Broadly neutralizing antibody responses in a large longitudinal sub-Saharan HIV primary infection cohort
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1005369
– volume: 503
  start-page: 277
  year: 2013
  ident: R59-20250608
  article-title: Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
  publication-title: Nature
  doi: 10.1038/nature12746
– volume: 90
  start-page: 6276
  year: 2016
  ident: R62-20250608
  article-title: Biphasic CD8 + T-cell defense in simian immunodeficiency virus control by acute-phase passive neutralizing antibody immunization
  publication-title: J Virol
  doi: 10.1128/JVI.00557-16
– volume: 21
  start-page: 113
  year: 2019
  ident: R23-20250608
  article-title: Human leukocyte antigen-associated gag and nef polymorphisms in HIV-1 subtype A/E-infected individuals in Vietnam
  publication-title: Microbes Infect
  doi: 10.1016/j.micinf.2018.10.001
– volume: 15
  start-page: e1007819
  year: 2019
  ident: R37-20250608
  article-title: Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1007819
– volume: 12
  start-page: e0189999
  year: 2017
  ident: R43-20250608
  article-title: HIV-1 envelope sequence-based diversity measures for identifying recent infections
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0189999
– volume: 6
  start-page: e26244
  year: 2011
  ident: R21-20250608
  article-title: Molecular characterization of HIV-1 CRF01_AE in mekong delta, vietnam, and impact of T-cell epitope mutations on HLA recognition (ANRS 12159)
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0026244
– volume: 508
  start-page: 46
  year: 2019
  ident: R27-20250608
  article-title: The role of conventional antibodies targeting the CD4 binding site and CD4-induced epitopes in the control of HIV-1 CRF01_AE viruses
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2018.11.063
– volume: 8
  start-page: 316
  year: 2015
  ident: R56-20250608
  article-title: Restricted isotype, distinct variable gene usage, and high rate of gp120 specificity of HIV-1 envelope-specific B cells in colostrum compared with those in blood of HIV-1-infected, lactating African women
  publication-title: Mucosal Immunol
  doi: 10.1038/mi.2014.69
– volume: 458
  start-page: 641
  year: 2009
  ident: R4-20250608
  article-title: Adaptation of HIV-1 to human leukocyte antigen class I
  publication-title: Nature
  doi: 10.1038/nature07746
– volume: 35
  start-page: 2281
  year: 2021
  ident: R63-20250608
  article-title: Late-phase dominance of a single epitope-specific CD8+ T-cell response in passive neutralizing antibody-infused SIV controllers
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000003013
– volume: 9
  start-page: e1003738
  year: 2013
  ident: R11-20250608
  article-title: Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypes
  publication-title: PLoS Pathog
  doi: 10.1371/journal.ppat.1003738
– volume: 17
  start-page: 19053
  year: 2014
  ident: R28-20250608
  article-title: HIV multidrug resistance at first-line antiretroviral failure and subsequent virological response in Asia
  publication-title: J Int AIDS Soc
  doi: 10.7448/IAS.17.1.19053
– volume: 6
  start-page: e24078
  year: 2011
  ident: R48-20250608
  article-title: Memory B cell antibodies to HIV-1 gp140 cloned from individuals infected with Clade A and B viruses
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0024078
– volume: 422
  start-page: 307
  year: 2003
  ident: R52-20250608
  article-title: Antibody neutralization and escape by HIV-1
  publication-title: Nature
  doi: 10.1038/nature01470
– volume: 503
  start-page: 224
  year: 2013
  ident: R60-20250608
  article-title: Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
  publication-title: Nature
  doi: 10.1038/nature12744
– volume: 12
  start-page: 448
  year: 2012
  ident: R29-20250608
  article-title: Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam
  publication-title: Infect Genet Evol
  doi: 10.1016/j.meegid.2011.04.034
– volume: 89
  start-page: 4201
  year: 2015
  ident: R36-20250608
  article-title: HIV-1 fitness cost associated with escape from the VRC01 class of CD4 binding site neutralizing antibodies
  publication-title: J Virol
  doi: 10.1128/JVI.03608-14
– volume: 9
  start-page: 22
  year: 2012
  ident: R42-20250608
  article-title: Timing and source of subtype-C HIV-1 superinfection in the newly infected partner of Zambian couples with disparate viruses
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-9-22
– volume: 458
  start-page: 636
  year: 2009
  ident: R45-20250608
  article-title: Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
  publication-title: Nature
  doi: 10.1038/nature07930
– volume: 91
  start-page: e00828
  year: 2017
  ident: R10-20250608
  article-title: Cooperation between strain-specific and broadly neutralizing responses limited viral escape and prolonged the exposure of the broadly neutralizing epitope
  publication-title: J Virol
  doi: 10.1128/JVI.00828-17
– volume: 75
  start-page: 10892
  year: 2001
  ident: R51-20250608
  article-title: Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41
  publication-title: J Virol
  doi: 10.1128/JVI.75.22.10892-10905.2001
– volume: 6
  start-page: e1000107
  year: 2009
  ident: R8-20250608
  article-title: Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 Infection
  publication-title: PLoS Med
  doi: 10.1371/journal.pmed.1000107
– volume: 18
  start-page: 1688
  year: 2012
  ident: R13-20250608
  article-title: Evolution of an HIV glycan-dependent broadly neutralizing antibody epitope through immune escape
  publication-title: Nat Med
  doi: 10.1038/nm.2985
– volume: 543
  start-page: 559
  year: 2017
  ident: R61-20250608
  article-title: Early antibody therapy can induce long-lasting immunity to SHIV
  publication-title: Nature
  doi: 10.1038/nature21435
– volume: 72
  start-page: 164
  year: 1998
  ident: R1-20250608
  article-title: Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques
  publication-title: J Virol
  doi: 10.1128/JVI.72.1.164-169.1998
– volume: 25
  start-page: 679
  year: 2011
  ident: R14-20250608
  article-title: Global trends in molecular epidemiology of HIV-1 during 2000–2007
  publication-title: AIDS
  doi: 10.1097/QAD.0b013e328342ff93
– volume: 19
  start-page: 925
  year: 2003
  ident: R16-20250608
  article-title: HIV type 1 isolates from 200 untreated individuals in Ho Chi Minh City (Vietnam): ANRS 1257 Study. Large predominance of CRF01_AE and presence of major resistance mutations to antiretroviral drugs
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/088922203322493111
– volume: 32
  start-page: 1917
  year: 2018
  ident: R44-20250608
  article-title: Phenotypic properties of envelope glycoproteins of transmitted HIV-1 variants from patients belonging to transmission chains
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000001906
– volume: 9
  start-page: 101
  year: 2016
  ident: R34-20250608
  article-title: Role of flow cytometry in the diagnosis and prognosis of plasma cell myeloma
  publication-title: Surg Pathol Clin
  doi: 10.1016/j.path.2015.09.009
– volume: 361
  start-page: 2209
  year: 2009
  ident: R31-20250608
  article-title: Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0908492
– volume: 397
  start-page: 7
  year: 2010
  ident: R40-20250608
  article-title: Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV
  publication-title: Virology
  doi: 10.1016/j.virol.2009.11.003
– volume: 496
  start-page: 469
  year: 2013
  ident: R9-20250608
  article-title: Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
  publication-title: Nature
  doi: 10.1038/nature12053
– volume: 36
  start-page: 7700
  year: 2018
  ident: R30-20250608
  article-title: V4 region of the HIV-1 envelope gene mediates immune escape and may not promote the development of broadly neutralizing antibodies
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2018.10.084
– volume: 183
  start-page: 2708
  year: 2009
  ident: R41-20250608
  article-title: HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0901068
– volume: 100
  start-page: 511
  year: 2019
  ident: R18-20250608
  article-title: Increased predominance of HIV-1 CRF01_AE and its recombinants in the Philippines
  publication-title: J Gen Virol
  doi: 10.1099/jgv.0.001198
– volume: 21
  start-page: 586
  year: 2005
  ident: R20-20250608
  article-title: Sequences of clustered epitopes in Gag and Nef potentially presented by predominant class I human leukocyte antigen (HLA) alleles A and B expressed by human immunodeficiency virus type 1 (HIV-1)-infected patients in Vietnam
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2005.21.586
– volume: 67
  start-page: 6642
  year: 1993
  ident: R50-20250608
  article-title: A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1
  publication-title: J Virol
  doi: 10.1128/jvi.67.11.6642-6647.1993
– volume: 158
  start-page: 481
  year: 2014
  ident: R12-20250608
  article-title: Cooperation of B cell lineages in induction of HIV-1-broadly neutralizing antibodies
  publication-title: Cell
  doi: 10.1016/j.cell.2014.06.022
– volume: 98
  start-page: 10362
  year: 2001
  ident: R7-20250608
  article-title: HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.181347898
– volume: 200
  start-page: 587
  year: 2004
  ident: R39-20250608
  article-title: Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily
  publication-title: J Exp Med
  doi: 10.1084/jem.20032236
– volume: 393
  start-page: 648
  year: 1998
  ident: R5-20250608
  article-title: Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody
  publication-title: Nature
  doi: 10.1038/31405
– volume: 14
  start-page: 1687
  year: 1998
  ident: R15-20250608
  article-title: Short communication: HIV type 1 subtypes in malaysia, determined with serologic assays: 1992–1996
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.1998.14.1687
– volume: 34
  start-page: 1603
  year: 2020
  ident: R55-20250608
  article-title: Higher frequencies of functional HIV-envelope-specific memory B cells are associated with nonprogressive HIV infection in Indian population
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000002620
– volume: 30
  start-page: 681
  year: 2016
  ident: R22-20250608
  article-title: A strong association of human leukocyte antigen-associated Pol and Gag mutations with clinical parameters in HIV-1 subtype A/E infection
  publication-title: AIDS
  doi: 10.1097/QAD.0000000000000969
– volume: 11
  start-page: 615
  year: 2005
  ident: R58-20250608
  article-title: Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies
  publication-title: Nat Med
  doi: 10.1038/nm1244
– volume: 343
  start-page: 65
  year: 2009
  ident: R47-20250608
  article-title: A method for identification of HIV gp140 binding memory B cells in human blood
  publication-title: J Immunol Methods
  doi: 10.1016/j.jim.2008.11.012
– volume: 15
  start-page: 160
  year: 2015
  ident: R33-20250608
  article-title: The generation of antibody-secreting plasma cells
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri3795
– volume: 329
  start-page: 811
  year: 2010
  ident: R35-20250608
  article-title: Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01
  publication-title: Science
  doi: 10.1126/science.1192819
– volume: 108
  start-page: 1580
  year: 2006
  ident: R38-20250608
  article-title: Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection
  publication-title: Blood
  doi: 10.1182/blood-2005-11-013383
– volume: 5
  start-page: e8805
  year: 2010
  ident: R49-20250608
  article-title: Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0008805
– volume: 10
  start-page: 62648
  year: 2021
  ident: R57-20250608
  article-title: Distinct clonal evolution of B-cells in HIV controllers with neutralizing antibody breadth
  publication-title: eLife
  doi: 10.7554/eLife.62648
– volume: 10
  start-page: e0114947
  year: 2015
  ident: R32-20250608
  article-title: Recalibration of the limiting antigen avidity EIA to determine mean duration of recent infection in divergent HIV-1 subtypes
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0114947
– volume: 18
  start-page: 346
  year: 2016
  ident: R25-20250608
  article-title: Neutralization breadth and potency of serum derived from recently human immunodeficiency virus type 1-infected Thai individuals
  publication-title: Microbes Infect
  doi: 10.1016/j.micinf.2015.12.009
– volume: 301
  start-page: 1374
  year: 2003
  ident: R46-20250608
  article-title: Predominant autoantibody production by early human B cell precursors
  publication-title: Science
  doi: 10.1126/science.1086907
– volume: 83
  start-page: 188
  year: 2009
  ident: R54-20250608
  article-title: Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies
  publication-title: J Virol
  doi: 10.1128/JVI.01583-08
– volume: 11
  start-page: 32
  year: 2014
  ident: R24-20250608
  article-title: Impact of amino acid substitutions in the V2 and C2 regions of human immunodeficiency virus type 1 CRF01_AE envelope glycoprotein gp120 on viral neutralization susceptibility to broadly neutralizing antibodies specific for the CD4 binding site
  publication-title: Retrovirology
  doi: 10.1186/1742-4690-11-32
– volume: 163
  start-page: 3303
  year: 2018
  ident: R26-20250608
  article-title: Evaluation of susceptibility of HIV-1 CRF01_AE variants to neutralization by a panel of broadly neutralizing antibodies
  publication-title: Arch Virol
  doi: 10.1007/s00705-018-4011-7
– volume: 32
  start-page: 851
  year: 2016
  ident: R17-20250608
  article-title: Nationwide trends in molecular epidemiology of HIV-1 in China
  publication-title: AIDS Res Hum Retroviruses
  doi: 10.1089/aid.2016.0029
SSID ssj0005088
Score 2.4036748
Snippet In HIV type 1 (HIV-1) infection, virus-specific B-cell and neutralizing antibody (NAb) responses are impaired but exert selective pressure on target viral...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1629
SubjectTerms Antibodies, Neutralizing
Cell Differentiation
HIV Antibodies
HIV Infections
HIV-1 - genetics
Humans
Title Association of envelope-specific B-cell differentiation and viral selective pressure signatures in HIV-1 CRF01_AE infection
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00002030-202210010-00003
https://www.ncbi.nlm.nih.gov/pubmed/35848590
https://www.proquest.com/docview/2691460730
Volume 36
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBahg7Exyu5Ld0GDvQVtdmRb0WPWC8lGBlvb0TcjyXIbGuzRJJR2v2r_cEeSL2qSsXWBmESRHFvns3SO9J1zEHoXxowmmoVEaarBQAljwmXIiaKg_WeaMimNg_PkSzI6jj6dxCedzi-PtbRcyPfqeqNfyf9IFcpArsZL9haSbU4KBfAZ5AtHkDAc_0nGXt8apU8XlgCkiXGfNBSg3kdiFuabLCiLqq5ZLDfk3llvbtPgGPaQJcSa3QTD6LDRPi1TdjT-TsLe7reDIEyH-w13q_CV2uF479BPDcLbYW1p8QDz4anJEArvpbcRcja9FpfCeQzNxXnZNrsQmS0_PJue6qsSara7F27FdnLVGwl_yQKs3Zr8Vi1ZbAg9YZcspjPDC_JGwH7CCehPgT9cu3gpNSz73uAbJtUN6uqrC6m1Nkm44MNfh3sueGX1otQ5Pq-E3w7cZm1AzI2YgFXWEd_El73TB8vEWvHjzy2rKLCpTpsrr701Ofuw6Q9vakNrJs599OCyNKyJ-bl1mvBUn6OHaLuyWfDQAfAR6ujiMbo7qVgZT9BPD4e4zPEaDrHDIV7BIQYcYotD3OAQ1zjELQ7xtMAWh7jGIW5w-BQdH-wf7Y5IldSDqAimD8IzxmTCmYLRn0ulEg1aaB7kkVShYCzUMma5ipga9Fkijb2cxSKJeJILFmua0WdoqygL_QJhsETkgAqR5ZpHIfT4gOlM59BcDjSosl1E685NVRXx3iRemaU18wJEkq6KpItI0-qHi_jyl_pva7mlMDSb7hSFLpfzFK4I9BAzh3bRcyfQ5owUFP9BzOEXckPCqXN_Tv8Eu51b1n-J7rVP4Cu0tbhY6tegRi_kGwvc30_evPE
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Association+of+envelope-specific+B-cell+differentiation+and+viral+selective+pressure+signatures+in+HIV-1+CRF01_AE+infection&rft.jtitle=AIDS+%28London%29&rft.au=Hau%2C+Trang+Thi+Thu&rft.au=Nishizawa%2C+Masako&rft.au=Harada%2C+Shigeyoshi&rft.au=Phan%2C+My+Ha&rft.date=2022-10-01&rft.pub=Lippincott+Williams+%26+Wilkins&rft.issn=0269-9370&rft.volume=36&rft.issue=12&rft.spage=1629&rft.epage=1641&rft_id=info:doi/10.1097%2FQAD.0000000000003323&rft.externalDocID=00002030-202210010-00003
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-9370&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-9370&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-9370&client=summon